{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:34:44Z","timestamp":1788381284896,"version":"build-2803163510"},"reference-count":37,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"AstraZeneca and Sanofi"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2380110","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T06:24:50Z","timestamp":1723184690000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Respiratory syncytial virus immunization patterns in Germany, 2015\u20132020"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3032-6354","authenticated-orcid":false,"given":"Moritz","family":"Wick","sequence":"first","affiliation":[{"name":"Sanofi-Aventis Deutschland GmbH","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4476-4460","authenticated-orcid":false,"given":"Roman","family":"Kliemt","sequence":"additional","affiliation":[{"name":"WIG2 GmbH","place":["Leipzig, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-5617","authenticated-orcid":false,"given":"Anahita","family":"Poshtiban","sequence":"additional","affiliation":[{"name":"Sanofi-Aventis Deutschland GmbH","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-3898","authenticated-orcid":false,"given":"Nils","family":"Kossack","sequence":"additional","affiliation":[{"name":"WIG2 GmbH","place":["Leipzig, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3050-5248","authenticated-orcid":false,"given":"Gerhard-Paul","family":"Diller","sequence":"additional","affiliation":[{"name":"University Hospital Muenster","place":["Muenster, Germany"]},{"name":"Deutsches Herzzentrum Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4523-6588","authenticated-orcid":false,"given":"Samira","family":"Soudani","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-8145","authenticated-orcid":false,"given":"Mathieu","family":"Bangert","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6095-4338","authenticated-orcid":false,"given":"Rolf","family":"Kramer","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-3655","authenticated-orcid":false,"given":"Oliver","family":"Damm","sequence":"additional","affiliation":[{"name":"Sanofi-Aventis Deutschland GmbH","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0123-0"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00478-0"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30938-8"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1681014"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0130-1"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1736581"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz150"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0142-x"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz492"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz087"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0303"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3611"},{"key":"e_1_3_4_14_1","unstructured":"European Medicines Agency. Abrysvo - respiratory syncytial virus vaccine (bivalent recombinant). Annex I - Summary of product characteristics. 2023 [accessed 2024 Jan 16]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/abrysvo-epar-product-information_en.pdf."},{"key":"e_1_3_4_15_1","unstructured":"European Medicines Agency. Beyfortus - nirsevimab. Annex I - Summary of product characteristics. 2024 [accessed 2024 Jan 16]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/beyfortus-epar-product-information_en.pdf."},{"key":"e_1_3_4_16_1","unstructured":"European Medicines Agency. Synagis - palivizumab. Annex I - Summary of product characteristics. 2023 [accessed 2024 Jan 16]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/synagis-epar-product-information_en.pdf."},{"key":"e_1_3_4_17_1","unstructured":"Bundesausschuss G. Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie in Anlage 4: Therapiehinweis zu Palivizumab [BAnz. Nr. 181 (S. 4 260) vom 27.11.2008]. 2008 [accessed 2024 Jan 10]. https:\/\/www.g-ba.de\/downloads\/39-261-694\/2008-06-19-AMR4-Palivizumab_BAnz.pdf."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19700"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3655"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12665"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06399-8"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317706"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab571"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-59"},{"key":"e_1_3_4_25_1","unstructured":"Bundesamt f\u00fcr Soziale Sicherung. Risikostrukturausgleich. Datenzusammenstellungen und Auswertungen - SA-Statistiken. 2024 [accessed 2024 Jan 9]. https:\/\/www.bundesamtsozialesicherung.de\/de\/themen\/risikostrukturausgleich\/datenzusammenstellungen-und-auswertungen\/."},{"key":"e_1_3_4_26_1","unstructured":"Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen. Bundesauswertung zum Erfassungsjahr 2017 - Geburtshilfe. Qualit\u00e4tsindikatoren. 2018 [accessed 2024 Jan 15]. https:\/\/iqtig.org\/downloads\/auswertung\/2017\/16n1gebh\/QSKH_16n1-GEBH_2017_BUAW_V02_2018-08-01.pdf."},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12281"},{"key":"e_1_3_4_28_1","unstructured":"Techniker Krankenkasse. Wieder mehr Fr\u00fchgeburten. Pressemitteilung. 2023 [accessed 2024 Jan 14]. https:\/\/www.tk.de\/presse\/themen\/praevention\/gesund-leben\/wieder-mehr-fruehgeburten-2160880."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1254155"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-011-0355-7"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0127-7"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1646240"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1270515"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2018.1401926"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-0595-7771"},{"key":"e_1_3_4_36_1","unstructured":"Deutsche Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie. S2k-Leitlinie \u201cLeitlinie zur Prophylaxe von schweren Erkrankungen durch Respiratory Syncytial Virus (RSV) bei Risikokindern\u201d Aktualisierung 2017\/2018. 2018 [accessed 2024 Jan 17]. https:\/\/register.awmf.org\/assets\/guidelines\/048-012l_S2k_Prophylaxe-von-schweren_RSV-Erkrankungen- Risikokindern-Palivizumab_2018-11.pdf."},{"key":"e_1_3_4_37_1","unstructured":"Deutsche Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie. 2k-Leitlinie \u201cLeitlinie zur Prophylaxe von schweren Erkrankungen durch Respiratory Syncytial Virus (RSV) bei Risikokindern\u201d Aktualisierung 2023 | Version 5.1. 2023 [accessed 2024 Jan 17]. https:\/\/register.awmf.org\/assets\/guidelines\/048-012l_S2k_Prophylaxe-von-schweren-Erkrankungen-durch-Respiratory-Syncytial-Virus-RSV-bei-Risikokindern_2023-10.pdf."},{"key":"e_1_3_4_38_1","unstructured":"Bundesausschuss G. Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses zur \u00c4nderung der Arzneimittel-Richtlinie: Anlage IV (Therapiehinweise) \u2013 Palivizumab. BAnz AT 17.01.2024 B2. 2023 [accessed 2024 Jan 17]. https:\/\/www.g-ba.de\/beschluesse\/6264\/."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2380110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:33:01Z","timestamp":1744651981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2380110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2380110"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2380110","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2380110"}}